1075756-90-9 Usage
General Description
1-(3,5-difluoropyridin-2-yl)ethanone is a chemical compound characterized by its combination of the fluoropyridine and ethanone functional groups. It has two fluorine substituents on the pyridine ring at positions 3 and 5, attached to an ethanone group by a single bond. While there isn't much specific information available publicly regarding this compound, it likely possesses unique properties due to the influence of the electronegative fluorine atoms and the polar ethanone group. This chemical could potentially be used in various chemical synthesis processes and in the development of pharmaceuticals and materials, depending on its reactivity and other properties, although its exact applications would need further research.
Check Digit Verification of cas no
The CAS Registry Mumber 1075756-90-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,7,5 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1075756-90:
(9*1)+(8*0)+(7*7)+(6*5)+(5*7)+(4*5)+(3*6)+(2*9)+(1*0)=179
179 % 10 = 9
So 1075756-90-9 is a valid CAS Registry Number.
1075756-90-9Relevant articles and documents
2-(IMIDAZ0LYLAMIN0)-PYRIDINE DERIVATIVES AND THEIR USE AS JAK KINASE INHIBITORS
-
Page/Page column 61, (2010/04/03)
The present inv ention relates to compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein Ring A is 5- or 6-membered heteroaryl, wherein said 5- or 6-membered heteroaryl is optionally substituted on carbon with one or more R6
TRICYCLIC 2,4-DIAMIN0-L,3,5-TRIAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER AND MYELOPROLIFERATIVE DISORDERS
-
Page/Page column 80-81, (2010/01/07)
The present invention relates to compounds of Formula (I): (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer.
CHEMICAL COMPOUNDS
-
Page/Page column 57, (2010/11/25)
This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.